MedPath

Myoring Versus Keraring Implantation for Keratoconus

Phase 2
Conditions
Keratoconus
Interventions
Other: Intrastromal corneal continuous ring (Myoring) implantation
Other: intrastromal corneal ring segments (Keraring) implantation
Registration Number
NCT01869517
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Various approaches, including surgical and non-surgical management have been proposed for keratoconus. One of the surgical procedures is Intrastromal Corneal Ring implantations that have been designed to achieve refractive readjustment by flattening the cornea. There are different models of Intrastromal Corneal rings available: intrastromal corneal ring segments (ICRS) such as Keraring and intrastromal corneal continuous ring (ICCR) like Myoring.

Most studies of these two types of ring implantation outcomes are retrospective case series. Thus, this Randomized Clinical Trial study was designed with the aim of Comparing visual and refractive outcomes and complications of insertion Myoring versus Keraring using Femtosecond laser. Keratoconus patients with compound myopic astigmatism who meet the inclusion criteria will randomly allocated to the Keraring and Myoring groups. Subsequently, the clinical outcomes of two groups will be compared at one,3 and 6 months after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
23
Inclusion Criteria
  • keratoconus patients and :
  • age between 20 to 40
  • corneal thickness> 380 microns
  • mean keratometry between 44 to 60 D
  • clear central cornea
  • Patients should be discontinued their contact lenses for 3 weeks prior to the exams
  • contact lenses in tolerance
  • 20/200<visual acuity <20/30
Exclusion Criteria
  • Positive pregnancy test
  • Breast-feeding
  • History of glaucoma, cataract, vernal and atopic keratoconjunctivitis
  • History of previous ophthalmologic surgery, keratorefractive surgery on the operative eye
  • Dry eye
  • Corneal stromal disorders
  • History of herpetic keratitis
  • Pellucid marginal degeneration
  • Corneal grafts
  • Retinal disorders
  • Nystagmus and uncooperative disposition
  • Neuro-ophthalmologic disorders
  • Intraocular pressure <10 mmHg or >21 mmHg
  • Patients with autoimmune, connective tissue disorders, diabetes and immunosuppressive drugs users
  • Hyperopia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intrastromal corneal continuous ring (Myoring)Intrastromal corneal continuous ring (Myoring) implantation-
Intrastromal corneal ring segments (Keraring)intrastromal corneal ring segments (Keraring) implantation-
Primary Outcome Measures
NameTimeMethod
uncorrected visual acuity6 months

Snellen E chart

Secondary Outcome Measures
NameTimeMethod
Corneal thickness6months

Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)

Corneal irregularities (3, 5 and 7 mm of central cornea)6 months

Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)

Front & back corneal elevation6 months

Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)

Corneal aberrometry6 months

Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)

Corneal eccentricity6 months

Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)

Corneal hysteresis & corneal resistance factor6 months

Ocular response Analyzer (reichert ophthalmic instruments, Buffalo,New York

,USA)

Intra and postoperative complications (glare, night vision problem, migration, extrusion, infection)Intra and post operatien

clinical examination, patients history

Trial Locations

Locations (1)

Islamic Republic OF Iran

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath